PsychoGenics Launches AI Platform to Revolutionize Drug Discovery
What You Should Know:– PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform.The platform supports phenotypic drug discovery, which unlike traditional target-based drug…
Continue Reading